Delivery Order SPE2DX22D0019-SPE2D826FCF62
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $4,241.60 delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively to the prime contractor's Conshohocken, Pennsylvania location. The delivery order represents a task order issued under AmerSourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,855.62 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was competitively awarded with no set-aside designation. The contract will be performed in Conshohocken, Pennsylvania, where AmerSourceBergen Drug Corp maintains its corporate office. This delivery order...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,262.65 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, represents a child award under a larger indefinite delivery contract vehicle. The contract was competitively awarded with no set-aside designation, and performance will occur at the awardee's Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,288.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc., a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,637.22 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order represents a child contract under the parent entity Cencora, Inc. (doing business as AmerSourceBergen), and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,374.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (Doing Business As AmerSourceBergen). This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion on January 7, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task...
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,122.80 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which was not set aside for any specific business category, represents a child contract under the company's parent organization Cencora, Inc. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken,...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCF62Delivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a $3,483.30 delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract (IDC) with Defense Logistics Agency Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerSourceBergen maintains its corporate headquarters and primary distribution operations for federal pharmaceutical procurement. AmerSourceBergen Drug Corp serves as a critical pharmaceutical distributor supporting military and veteran healthcare systems through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program. The parent company, Cencora, Inc., holds a significant IDC valued at up to $999,999,999.00 through December 2031, enabling the delivery of comprehensive pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order reflects the company's ongoing role in fulfilling essential medical supply requirements for Department of Defense healthcare programs on a firm fixed-price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/6/26 |